p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
- 20 February 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 13 (3), 310-316
- https://doi.org/10.1038/ncb2172
Abstract
Cancer cells preferentially use aerobic glycolysis to generate ATP, consuming glucose in the process. The tumour suppressor p53 is now shown to suppress glucose consumption by inhibiting the pentose phosphate pathway (PPP). Tumour-associated p53 mutations lack this inhibitory effect. Cancer cells consume large quantities of glucose and primarily use glycolysis for ATP production, even in the presence of adequate oxygen1,2. This metabolic signature (aerobic glycolysis or the Warburg effect) enables cancer cells to direct glucose to biosynthesis, supporting their rapid growth and proliferation3,4. However, both causes of the Warburg effect and its connection to biosynthesis are not well understood. Here we show that the tumour suppressor p53, the most frequently mutated gene in human tumours, inhibits the pentose phosphate pathway5 (PPP). Through the PPP, p53 suppresses glucose consumption, NADPH production and biosynthesis. The p53 protein binds to glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the PPP, and prevents the formation of the active dimer. Tumour-associated p53 mutants lack the G6PD-inhibitory activity. Therefore, enhanced PPP glucose flux due to p53 inactivation may increase glucose consumption and direct glucose towards biosynthesis in tumour cells.Keywords
This publication has 28 references indexed in Scilit:
- Characterization of Functional Domains Necessary for Mutant p53 Gain of FunctionOnline Journal of Public Health Informatics, 2010
- Suppression of p53 activity by Siva1Cell Death & Differentiation, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Cytoplasmic functions of the tumour suppressor p53Nature, 2009
- New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditureNature, 2008
- Critical role for Daxx in regulating Mdm2Nature, 2006
- A Novel Transcription Regulatory Complex Containing Death Domain-associated Protein and the ATR-X Syndrome ProteinJournal of Biological Chemistry, 2004
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutantsOncogene, 2001
- On the Origin of Cancer CellsScience, 1956